SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-21-006463
Filing Date
2021-09-14
Accepted
2021-09-14 08:32:23
Documents
2
Period of Report
2021-09-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_091421.htm 6-K 4496
2 PRESS RELEASE exh_991.htm EX-99.1 9432
  Complete submission text file 0001171843-21-006463.txt   14916
Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2
Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555
Medicenna Therapeutics Corp. (Filer) CIK: 0001807983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-39458 | Film No.: 211251282
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences